Enterocolitis, Pseudomembranous: Clinical Trials

1 trial for Enterocolitis, Pseudomembranous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Enterocolitis, Pseudomembranous: new trials by email Literature Review of Enterocolitis, Pseudomembranous trials Research Report on Enterocolitis, Pseudomembranous

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Trial of a Single Dose of CRS3123
CRS3123, Placebo - Clostridium Difficile Colitis
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)402012-05-222017-09-25

Broader conditions

Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Clostridium Infections (1)  ·  Digestive System Diseases (1)  ·  Enterocolitis (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Intestinal Diseases (1)

Interventions

REP 3123 (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (1)

Results publications

PMID 28584140